mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.8 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.8 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.8 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0094 |
0.8 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
AZD8055 |
GDSC1000 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |